Rockwell Medical, Inc. (RMTI)
7.985
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
7.985
0.00 (0.00%)
After-Hours: 20:00
Rockwell Medical Research and Development Expense (Quarterly) : 0.04M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.04M |
| March 31, 2026 | |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.001M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.018M |
| December 31, 2023 | 0.168M |
| September 30, 2023 | 0.494M |
| June 30, 2023 | 0.167M |
| March 31, 2023 | 0.278M |
| December 31, 2022 | 0.156M |
| September 30, 2022 | 0.469M |
| June 30, 2022 | 0.926M |
| March 31, 2022 | 1.567M |
| December 31, 2021 | 1.39M |
| September 30, 2021 | 1.221M |
| June 30, 2021 | 2.416M |
| March 31, 2021 | 1.809M |
| December 31, 2020 | 1.909M |
| September 30, 2020 | 1.745M |
| June 30, 2020 | 1.616M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.822M |
| December 31, 2019 | 1.956M |
| September 30, 2019 | 1.475M |
| June 30, 2019 | 2.958M |
| March 31, 2019 | 0.4973M |
| December 31, 2018 | 2.709M |
| September 30, 2018 | 0.8082M |
| June 30, 2018 | 1.559M |
| March 31, 2018 | 1.666M |
| December 31, 2017 | 2.126M |
| September 30, 2017 | 1.305M |
| June 30, 2017 | 1.676M |
| March 31, 2017 | 1.215M |
| December 31, 2016 | 1.201M |
| September 30, 2016 | 1.262M |
| June 30, 2016 | 2.063M |
| March 31, 2016 | 1.314M |
| December 31, 2015 | 2.030M |
| September 30, 2015 | 1.247M |
| June 30, 2015 | 0.8853M |
| March 31, 2015 | 0.7996M |
| December 31, 2014 | 1.680M |
| September 30, 2014 | 1.302M |
| June 30, 2014 | 0.1867M |
| March 31, 2014 | 4.615M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Kestra Medical Technologies Ltd. | 5.634M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |